Advanced search
Publication Cover
Leukemia & Lymphoma Volume 45, 2004 - Issue 8
Submit an article Journal homepage
164
Views
30
CrossRef citations to date
0
Altmetric
Short Communication

Subdural Hematomas during CML Therapy with Imatinib Mesylate

KW Song Department of Medical Oncology and Hematology, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, CanadaCorrespondence[email protected]
,
J Rifkind Department of Medical Oncology and Hematology, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada
,
B Al-Beirouti Department of Medical Oncology and Hematology, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada
,
K Yee Department of Medical Oncology and Hematology, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada
,
J McCrae Department of Medical Oncology and Hematology, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada
,
HA Messner Department of Medical Oncology and Hematology, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada
,
A Keating Department of Medical Oncology and Hematology, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada
&
JH Lipton Department of Medical Oncology and Hematology, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada
 show all
Pages 1633-1636 | Received 03 Aug 2003, Published online: 26 Aug 2009

Citations (30)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Sujin Choi, Jung Yoon Choi, Bo Kyung Kim, Hong Yul Ahn, Kyung Taek Hong, Jung-Eun Cheon, Hee Young Shin & Hyoung Jin Kang. (2021) Intracerebral hemorrhage as a rare complication of imatinib in a Philadelphia chromosome positive acute lymphoblastic leukemia pediatric patient. Pediatric Hematology and Oncology 38:4, pages 378-384.
Read now
Moaath K. Mustafa Ali, Marwa M. Sabha & Kamal H. Al-Rabi. (2015) Spontaneous subdural hematoma in a patient with Philadelphia chromosome-positive acute lymphoblastic leukemia with normal platelet count after dasatinib treatment. Platelets 26:5, pages 491-494.
Read now
Fabiana Baldi, Leonello Fuso, Eugenio Arrighi & Salvatore Valente. (2014) Optimal management of pulmonary arterial hypertension: prognostic indicators to determine treatment course. Therapeutics and Clinical Risk Management 10, pages 825-839.
Read now
Shiven B. Patel, Ivana Gojo, Michael L. Tidwell, Edward A. Sausville & Maria R. Baer. (2011) Subdural hematomas in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia receiving imatinib mesylate in conjunction with systemic and intrathecal chemotherapy. Leukemia & Lymphoma 52:7, pages 1211-1214.
Read now

Articles from other publishers (26)

Rida Aziz, Azeem Khan, Maryam Yousefi, Shivani Khetani & Hammad Choudhry. (2023) Spontaneous Non-Traumatic Mediastinal Hematoma in a Patient on Imatinib Therapy for a Gastrointestinal Stromal Tumor (GIST). Cureus.
Crossref
Lisa R. Rogers. 2022. Handbook of Neuro-Oncology Neuroimaging. Handbook of Neuro-Oncology Neuroimaging 87 91 .
Ankur Jain, Anupma Arora, Jyoti Singh, Ram N. Patarwal, Pooja Prasad, Sumita Chaudhry, Monica Sharma, Jitender Mohan Khunger, Dipender Kumar Gupta & Sumita Saluja. (2020) Prospective evaluation of variables affecting platelet function in patients with newly diagnosed chronic myeloid leukemia. Blood Coagulation & Fibrinolysis 31:8, pages 562-568.
Crossref
Shlomit Yust-Katz, Simon Khagi & Mark R. Gilbert. 2020. Abeloff's Clinical Oncology. Abeloff's Clinical Oncology 688 706.e7 .
Kien-Ninh Ina Ly & Isabel C. Arrillaga-Romany. (2018) Neurologic Complications of Systemic Anticancer Therapy. Neurologic Clinics 36:3, pages 627-651.
Crossref
Sooji SirhHye Ran Park & Sukh Que Park. (2018) Usefulness of Middle Meningeal Embolization to Prevent Recurrent Spontaneous Chronic Subdural Hemorrhage. Journal of Cerebrovascular and Endovascular Neurosurgery 20:1, pages 40.
Crossref
Deborah A. Forst & Patrick Y. Wen. 2018. Cancer Neurology in Clinical Practice. Cancer Neurology in Clinical Practice 311 333 .
Christian B. Theodotou, Ashish H. Shah, Michael E. Ivan & Ricardo J. Komotar. (2016) Subdural hematoma in a patient taking imatinib for GIST. Anti-Cancer Drugs 27:3, pages 259-263.
Crossref
Chaitra A. Badve & Lisa R. Rogers. 2016. Handbook of Neuro-Oncology Neuroimaging. Handbook of Neuro-Oncology Neuroimaging 85 88 .
Adaani E. Frost, Robyn J. Barst, Marius M. Hoeper, Hyuk-Jae Chang, Robert P. Frantz, Yoshihiro Fukumoto, Nazzareno Galié, Paul M. Hassoun, Hans Klose, Hiromi Matsubara, Nicholas W. Morrell, Andrew J. Peacock, Michael Pfeifer, Gérald Simonneau, Victor F. Tapson, Fernando Torres, Carmine Dario Vizza, David Lawrence, Wei Yang, James M. Felser, Deborah A. Quinn & Hossein-Ardeschir Ghofrani. (2015) Long-term safety and efficacy of imatinib in pulmonary arterial hypertension. The Journal of Heart and Lung Transplantation 34:11, pages 1366-1375.
Crossref
Luis Felipe Lopes Prada, Francisca Gavilanes & Rogério Souza. (2015) Incidence of spontaneous subdural hematoma in incident cases of pulmonary arterial hypertension: a registry of cases occurring over a five-year period. Jornal Brasileiro de Pneumologia 41:1, pages 101-102.
Crossref
Saman Ahmed & Harold I. Palevsky. (2014) Pulmonary Arterial Hypertension Related to Connective Tissue Disease. Rheumatic Disease Clinics of North America 40:1, pages 103-124.
Crossref
Shlomit Yust-Katz & Mark R. Gilbert. 2014. Abeloff's Clinical Oncology. Abeloff's Clinical Oncology 822 844.e6 .
Marius M. HoeperRobyn J. BarstRobert C. BourgeJeremy FeldmanAdaani E. FrostNazzareno GaliéMiguel Angel Gómez-SánchezFriedrich GrimmingerEkkehard GrünigPaul M. HassounNicholas W. MorrellAndrew J. PeacockToru SatohGérald SimonneauVictor F. TapsonFernando TorresDavid LawrenceDeborah A. QuinnHossein-Ardeschir Ghofrani. (2013) Imatinib Mesylate as Add-on Therapy for Pulmonary Arterial Hypertension. Circulation 127:10, pages 1128-1138.
Crossref
Nicholas A. Butowski & Susan M. Chang. 2012. Neuro-Oncology Part II. Neuro-Oncology Part II 937 945 .
Hanny Haaxma-Reiche. 2012. Neuro-Oncology Part II. Neuro-Oncology Part II 711 729 .
Eudocia C. Quant, David C. Fisher & Patrick Y. Wen. 2012. Lymphoma and Leukemia of the Nervous System. Lymphoma and Leukemia of the Nervous System 357 381 .
Caitlin E. O'Brien, Amanda M. Saratsis & Jean-Marc Voyadzis. (2011) Granulocytic Sarcoma in a Patient With Blast Crisis Mimicking a Chronic Subdural Hematoma. Journal of Clinical Oncology 29:19, pages e569-e571.
Crossref
Mohamed M. Abdulhamid, Yan Michael Li & Walter A. Hall. (2010) Spontaneous acute subdural hematoma as the initial manifestation of chronic myeloid leukemia. Journal of Neuro-Oncology 101:3, pages 513-516.
Crossref
Min Sik KimDong Hyun LeeYu Rim LeeDong Kyun KimSuk Hyang BaeJin Yeon HwangKyung A KwonSuee LeeJin Yeong HanKi Uk KimSung-Hyun Kim. (2010) A case of subdural hematoma in patient with chronic myeloid leukemia treated with high-dose imatinib mesylate. The Korean Journal of Hematology 45:1, pages 73.
Crossref
David Schiff, Patrick Y. Wen & Martin J. van den Bent. (2009) Neurological adverse effects caused by cytotoxic and targeted therapies. Nature Reviews Clinical Oncology 6:10, pages 596-603.
Crossref
Kosei Matsue, Takatoshi Aoki, Jun Odawara, Shun-ichi Kimura, Masayuki Yamakura & Masami Takeuchi. (2009) Haemorrhagic complications associated with reduced α2-plasmin inhibitor during imatinib use in a patient with Philadelphia chromosome-positive acute lymphoblastic leukaemia. Leukemia Research 33:6, pages 867-869.
Crossref
Jörg Dietrich & Patrick Y. Wen. 2008. Cancer Neurology In Clinical Practice. Cancer Neurology In Clinical Practice 287 326 .
Upendra Srinivas, Lakshmi S. Pillai, Rajat Kumar, H.P. Pati & Renu Saxena. (2007) Bone marrow aplasia—a rare complication of imatinib therapy in CML patients. American Journal of Hematology 82:4, pages 314-316.
Crossref
Peter H. Wiernik. (2006) Plasma cell dyscrasias and leukemias. Update on Cancer Therapeutics 1:4, pages 539-567.
Crossref
. (2004) Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 13:11.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.